3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Brain Neoplasms
3
Multiple Myeloma
2
Lymphoma
2
Prostatic Neoplasms
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Localized, Operable Non-small Cell Lung Cancer
1
Liver Neoplasms
1
Liver Diseases
1
Fibrosis
1
Fatigue
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Cancer Related Cognitive Difficulties
1
Breast Neoplasms
1
Interventions
Rituximab
45
Cyclophosphamide
32
Lenalidomide
24
fludarabine
20
zanubrutinib
13
venetoclax
12
obinutuzumab
12
orelabrutinib
11
fludarabine phosphate
10
Bendamustine Hydrochloride
10
Magnetic Resonance Spectroscopy
9
Whole-Body Irradiation
8
Prednisone
8
pirtobrutinib
7
ibrutinib
7
Vincristine
7
Specimen Handling
7
CT-P10
7
Mycophenolic Acid
6
Biopsy
6
Doxorubicin
5
tafasitamab
4
pembrolizumab
3
acalabrutinib
3
Tacrolimus
3
Sirolimus
3
Radiotherapy
3
Peripheral Blood Stem Cell Transplantation
3
Nivolumab
3
Melphalan
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
Neuropsychological Tests
×
1 year
×
Clear all
NCT07558057
2026-04-30
COGNITOX
University of Aarhus
Not yet recruiting
225 enrolled